|
Friday, 03 Feb 2012
Results from the prospective, multicentre clinical study show that 55% of patients who suffered a severe acute ischaemic stroke were restored to a good functional outcome [read more]
|
|
|
|
|
|
Friday, 03 Feb 2012
Occasional erratic heart rhythms appear to cause about one-fifth of strokes for which a cause is not readily established, according to research presented at the American Stroke Association’s International Stroke Conference 2012. [read more]
|
|
|
|
|
|
Thursday, 02 Feb 2012
A new analysis from a two-year follow up of participants in the CREST (Carotid revascularization endarterectomy versus stenting) trial show that carotid artery stenting and carotid endarterectomy are equally effective at halting carotid restenosis in stroke prevention. [read more]
|
|
|
|
|
|
Thursday, 02 Feb 2012
People with severe sleep apnea may have an increased risk of silent strokes and small lesions in the brain, according to a small study presented at the American Stroke Association’s International Stroke Conference 2012. [read more]
|
|
|
|
|
|
Tuesday, 31 Jan 2012
The Solitaire FR revascularisation device (Covidien) has been approved for investigational use in the thrombectomy arm of the IMS III (Interventional management of stroke) trial. [read more]
|
|
|
|
|
|
Tuesday, 24 Jan 2012
The Separator 3D is a next-generation clot engagement device that works in conjunction with aspiration at the site of the lesion causing an acute ischaemic stroke to remove the clot and restore blood flow to affected brain tissue. [read more]
|
|
|
|
|
|
Friday, 20 Jan 2012
The ALS phase I/II human clinical trial is being performed at Hadassah Medical Center in Israel in collaboration with BrainStorm and is utilising NurOwn technology (BrainStorm) for growing and modifying autologous adult human stem cells to treat ALS. [read more]
|
|
|
|
|
|
Friday, 20 Jan 2012
InVivo expects to submit data from the study to the US Food and Drug Administration (FDA) in 2012 representing the company’s first technology to treat degenerative neurologic conditions outside of the spinal cord. [read more]
|
|
|
|
|
|
Wednesday, 18 Jan 2012
The registry will gather information from valvular and non-valvular atrial fibrillation patients. It will also track the impact of new anticoagulant therapies on stroke prevention, in addition to collating insights into patients’ satisfaction with their entire atrial fibrillation management and the overall health economic burden of atrial fibrillation across Europe. [read more]
|
|
|
|
|
|
Wednesday, 18 Jan 2012
More than 90% of fibromuscular dysplasia sufferers are women, according to a registry presented at ISET 2012. High blood pressure and headache were found the most common symptoms. [read more]
|
|
|
|
|
